NovoCure Ltd. Revenue 2013–2025
NovoCure Ltd. annual/quarterly revenue history and growth rate from 2013 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- NovoCure Ltd. revenue for the quarter ending March 31, 2026 was 174.1 M, a 12.30% increase year-over-year.
- NovoCure Ltd. revenue for the twelve months ending March 31, 2026 was 655.1 M, a 14.67% increase year-over-year.
- NovoCure Ltd. annual revenue for 2025 was 655.4 M, a 8.28% increase from 2024.
- NovoCure Ltd. annual revenue for 2024 was 605.2 M, a 18.82% increase from 2023.
- NovoCure Ltd. annual revenue for 2023 was 509.3 M, a 5.30% decrease from 2022.
- NovoCure Ltd. annual revenue for 2022 was 537.8 M.
NovoCure Ltd. (NVCR) — Frequently Asked Questions
NovoCure Ltd. (NVCR) is a publicly traded US company. It has a market capitalization of $1.96B. In fiscal 2025 it reported revenue of $655M and net income of -$136M. Explore NVCR's stock price, financial statements, earnings history, margins and key ratios below.
What is NovoCure Ltd.'s market cap?
NovoCure Ltd. (NVCR) has a market capitalization of $1.96B.
What is the NVCR stock price?
NVCR trades at $17.57 (+5.53% on the day).
How much revenue does NovoCure Ltd. make?
NovoCure Ltd. reported revenue of $655M in fiscal 2025.
Is NVCR profitable?
In fiscal 2025, NovoCure Ltd. reported net income of -$136M.